United Therapeutics Corporation (UTHR)
NASDAQ
The current UTHR market cap is 15.63B. The company's latest EPS is USD 22.1347 and P/E is 15.87.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 596.5M | 609.4M | 614.7M | 677.7M | 714.9M |
Operating Income | 313.4M | 327M | 260.1M | 356.3M | 319.9M |
Net Income | 259.2M | 267.6M | 217.1M | 306.6M | 278.1M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.45B | 1.48B | 1.69B | 1.94B | 2.33B |
Operating Income | -187.6M | 593.6M | 442.5M | 979.7M | 1.18B |
Net Income | -104.5M | 514.8M | 362.4M | 727.3M | 984.8M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 6.68B | 7.02B | 7.17B | 6.5B | 6.72B |
Total Liabilities | 1.27B | 1.31B | 1.18B | 1.16B | 1.03B |
Total Equity | 5.41B | 5.71B | 5.98B | 5.34B | 5.7B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.91B | 4.62B | 5.17B | 6.04B | 7.17B |
Total Liabilities | 1.13B | 1.22B | 1.21B | 1.25B | 1.18B |
Total Equity | 2.78B | 3.4B | 3.96B | 4.8B | 5.98B |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 481.1M | 827.3M | 978M | 376.5M | 608.7M |
Investing | -448.3M | -761.7M | -719.6M | 735.3M | 655.3M |
Financing | 73.3M | 80.9M | -11.9M | -1.07B | -1.12B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -206.6M | 755.7M | 598.2M | 802.5M | 978M |
Investing | -335.4M | -738.5M | -486.9M | -811.5M | -719.6M |
Financing | 611.2M | -16.9M | 44.8M | 75.4M | -11.9M |
Market Cap | 15.63B |
Price to Earnings Ratio | 15.87 |
Price to Sales Ratio | 6.72 |
Price to Cash Ratio | 12.94 |
Price to Book Ratio | 2.61 |
Dividend Yield | - |
Shares Outstanding | 44.49M |
Average Volume (1 week) | 398.98k |
Average Volume (1 Month) | 373.68k |
52 Week Change | 57.91% |
52 Week High | 365.98 |
52 Week Low | 208.6249 |
Spread (Intraday) | 3.99 (1.12%) |
Company Name | United Therapeutics Corporation |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.unither.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.